NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹47 Cr | ₹46 Cr | ₹50 Cr | ₹34 Cr | ₹32 Cr |
What is the latest Short Term Loans and Advances ratio of NEULAND LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2023 | ₹47 Cr |
Mar2022 | ₹46 Cr |
Mar2021 | ₹50 Cr |
Mar2020 | ₹34 Cr |
Mar2019 | ₹32 Cr |
How is Short Term Loans and Advances of NEULAND LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2023 | ₹47 Cr | 2.37 | |
Mar2022 | ₹46 Cr | -7.16 | |
Mar2021 | ₹50 Cr | 46.59 | |
Mar2020 | ₹34 Cr | 6.41 | |
Mar2019 | ₹32 Cr | - |
Compare Short Term Loans and Advances of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹9,220.0 Cr | -4.5% | 11.6% | 248.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -4.5% |
11.6% |
248.9% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses